R13
Sign inGet started
🇫🇷

ABOLIS BIOTECHNOLOGIES

SIC72.11ZID801679614VATFR96801679614👥20employeesCapital€21K

📍 5 RUE HENRI DESBRUERES 91000 EVRY-COURCOURONNES

Financial data

Sign in to unlock
Revenue
•••••
EBIT
•••••
EBITDA
•••••
Net result
•••••
Fiscal year
2024
Revenue, EBIT, net result and balance-sheet figures are as reported to the public register. EBITDA marked Estimated is derived from revenue × the sector-average margin (used where EBITDA is not publicly filed, e.g. France) and is not an audited figure.
Financial ratios — pre-computed profitability, liquidity, gearing and working-capital metrics from the latest filed accounts (INPI). Unlock to view.

Other companies in this sector

Same country and activity, ranked by how much data we hold. The list is free — open any company to see its own page.

SYNGENTA FRANCE SAfinancials→INSTITUT SERVIER D'INNOVATION THERAPEUTIQUEfinancials→IPSEN INNOVATIONfinancials→IMMUNOTECHfinancials→ORPHALAN (GMPO)financials→OSE IMMUNOTHERAPEUTICSfinancials→

Direction

4
Sign in to unlock
  • •••••••••••
    •••••
  • •••••••••••
    •••••
  • •••••••••••
    •••••
2 board members · 2 corporate officers · unlocks alongside financials

ESG

Cross-referenced against public registries. Updated daily.

Conventions collectives

Establishments

1
SIRETAddressNAFStatus
••• ••• ••• •••••siège•• rue ••••••, ••••• Paris••.••Zactive

Recent events (BODACC)

118 more behind unlock
DateTypeLabelTribunal
2025-••-••DPC•••••••••••• ••••••Tribunal de •••••••
2025-••-••VENTE•••••••••••• ••••••Tribunal de •••••••
2025-••-••MODIFICATION•••••••••••• ••••••Tribunal de •••••••

Data sourced from official commercial registries. Last updated when this company filed its accounts.